J Med Microbiol Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rupnik, M.
Right arrow Articles by von Eichel-Streiber, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rupnik, M.
Right arrow Articles by von Eichel-Streiber, C.
Agricola
Right arrow Articles by Rupnik, M.
Right arrow Articles by von Eichel-Streiber, C.
J Med Microbiol 54 (2005), 113-117; DOI: 10.1099/jmm.0.45810-0
© 2005 Society for General Microbiology
ISSN 0022-2615

Revised nomenclature of Clostridium difficile toxins and associated genes

Maja Rupnik1, Bruno Dupuy2, Neil F Fairweather3, Dale N Gerding4,5, Stuart Johnson4,5, Ingo Just6, David M Lyerly7, Michel R Popoff8, Julian I Rood9, Abraham L Sonenshein10, Monica Thelestam11, Brendan W Wren12, Tracy D Wilkins7 and Christoph von Eichel-Streiber13

1University of Ljubljana, Department of Biology, Vecna pot 111, 1000 Ljubljana, Slovenia 2,8Unité de Génétique Moléculaire Bactérienne2 and Unité des Toxines Microbiennes8, Institut Pasteur, Paris, France 3Centre for Molecular Microbiology and Infection, Imperial College, London, UK 4Hines VA Hospital, Hospital/151 Fifth Avenue & Roosevelt Road, Hines, IL 60141, USA 5Loyola University Medical Center, 2160 South First Avenue, Maywood, IL 60153, USA 6Institute of Toxicology, Hannover Medical School, Hannover, Germany 7TechLab Inc., Blacksburg, VA, USA 9Australian Bacterial Pathogenesis Program, Department of Microbiology, Monash University, Victoria 3800, Australia 10Department of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, MA, USA 11Microbiology and Tumorbiology Center, Karolinska Institute, Stockholm, Sweden 12London School of Hygiene and Tropical Medicine, University of London, UK 13Institute of Medical Microbiology and Hygiene, Johannes Gutenberg University of Mainz, D-55101 Mainz, Germany

Correspondence Maja Rupnik maja.rupnik{at}bf.uni-lj.si

Received July 3, 2004
Accepted August 6, 2004

Several different nomenclatures have been applied to the Clostridium difficile toxins and their associated genes. This paper summarizes the new nomenclature that has been agreed to by the research groups currently active in the field. The revised nomenclature includes C. difficile toxins and other related large clostridial toxins produced by Clostridium sordellii and Clostridium novyi, and corresponding toxin genes, as well as toxin production types of C. difficile strains.


This paper was presented at the round-table discussion on Clostridium difficile nomenclature at the First International Clostridium difficile Symposium, Kranjska Gora, Slovenia, 5–7 May 2004.

Abbreviation: LCT, large clostridial toxin.


    INTRODUCTION
 TOP
 INTRODUCTION
 REVISED NOMENCLATURE
 REFERENCES
 
Clostridium difficile is the causative agent of antibiotic-associated diarrhoea and pseudomembranous colitis. Two large protein cytotoxins, toxin A (TcdA) and toxin B (TcdB), are recognized as the main virulence factors. Some C. difficile strains also produce a third, unrelated toxin (binary toxin CDT).

The molecular analysis of C. difficile toxins started in the 1980s with the first attempts to clone fragments of toxin genes and has progressed with the sequencing of both toxin genes (von Eichel-Streiber & Sauerborn, 1990; von Eichel-Streiber et al., 1990, 1992; Dove et al., 1990; Johnson et al., 1990), with the definition of the region encoding the toxins (Hammond & Johnson, 1995; Braun et al., 1996), and with studies of toxin gene regulation (Moncrief et al., 1997; Hammond et al., 1997; Hundsberger et al., 1997; Dupuy & Sonenshein, 1998; Mani & Dupuy, 2001). Unfortunately, in parallel with developments on the molecular biology and biochemistry of C. difficile, several different nomenclature systems have been applied to the toxins and their associated genes (Table 1).


View this table:
[in this window]
[in a new window]
 
Table 1. Names previously used for C. difficile toxins and toxin genes (see also Fig. 1) From references: Braun et al. (1996); Dupuy & Sonenshein (1998); Fiorentini et al. (1998); Green et al. (1995); Hammond & Johnson (1995); Hammond et al. (1997); Hofmann et al. (1995); Johnson et al. (1990); Dove et al. (1990); Karlsson et al. (2003); Mani & Dupuy (2001); Moncrief et al. (1997); Spigaglia & Mastrantonio (2002); von Eichel-Streiber et al. (1990, 1992).
 

With an increasing number of research groups working on the molecular biology of C. difficile, or using its toxins as tools in cell biology, and with the imminent finalization of the first C. difficile genome sequence (http://www.sanger.ac.uk/Projects/C_difficile/), the need for a unified nomenclature has become apparent. A similar approach was taken on naming the clostridial neurotoxins, where a proposed unified nomenclature (Niemann, 1992) has resulted in consistent and logical citation in the literature.

At the recent First International C. difficile Symposium (FICDS, Kranjska Gora, Slovenia, May 2004), a round-table discussion on C. difficile toxins and toxin gene nomenclature was held. This paper summarizes the new nomenclature that was agreed to by the research groups currently active in the field.


    REVISED NOMENCLATURE
 TOP
 INTRODUCTION
 REVISED NOMENCLATURE
 REFERENCES
 
Large clostridial toxins (LCTs) and toxin genes

C. difficile produces three toxins: toxin A (TcdA), toxin B (TcdB) and binary toxin (CDT). Toxins A and B are similar to one another, and belong, together with three other toxins produced by Clostridium sordellii and Clostridium novyi, to the well-defined group of LCTs (von Eichel-Streiber et al., 1996). The structural genes encoding four of the five LCTs have been sequenced (von Eichel-Streiber & Sauerborn, 1990; von Eichel-Streiber et al., 1990, 1992; Dove et al., 1990; Johnson et al., 1990; Green et al., 1995; Hofmann et al., 1995), and in 1995 a nomenclature for LCTs and their genes was proposed that combines information on the bacterial species and the identity of the toxin (Hofmann et al., 1995): Tcd for C. difficile, Tcs for C. sordellii and Tcn for C. novyi; and TcdA and TcdB for toxin A and toxin B, TcsL and TcsH for toxin LT and HT, and Tcn{alpha} (Tcn-alpha) for the alpha toxin of C. novyi.

At the Slovenia meeting it was agreed that a unified nomenclature should be based on the tcd–tcs–tcn system (Table 2) as it is recommended that homologous genes present in different organisms receive the same or similar names (Demerec et al., 1966).


View this table:
[in this window]
[in a new window]
 
Table 2. Revised unified nomenclature for C. difficile and related large clostridial toxins
 

The genomic region encoding the C. difficile toxins

A 19 kb region encoding two related toxins produced by C. difficile (toxin A or TcdA and toxin B or TcdB) has been defined as the toxigenic element (Hammond & Johnson, 1995) or as the pathogenicity locus, PaLoc (Braun et al., 1996). As the latter name has been used predominately in recent publications, we suggest accepting it for the new C. difficile nomenclature.

However, it is important to stress that although the use of the term ‘pathogenicity locus’ or ‘PaLoc’ is correct, the term ‘pathogenicity island’ is not an accurate description of this gene region since there is no evidence that the PaLoc region is horizontally acquired and it does not fit the generally accepted definition of a pathogenicity island (Hacker et al., 2004).

C. difficile LCT genes and associated genes

For the C. difficile genes found in the PaLoc the nomenclature shown in Table 2 and Fig. 1 was agreed. The genes for toxins A and B should be called tcdA and tcdB, respectively. The other three genes were previously defined as tcdC, D and E by the von Eichel-Streiber group according to the predicted sizes of the encoded proteins and not according to their relative positions in the PaLoc (Braun et al., 1996). As the names tcdE and tcdC have been used in recent publications by several different groups, these two names will remain.



View larger version (6K):
[in this window]
[in a new window]
 
Fig. 1. Revised nomenclature for five genes of the C. difficile pathogenicity locus PaLoc.

 

However, the majority of papers dealing with the tcdD gene use the name txeR. To be consistent with the tcd nomenclature, which indicates that the gene is a part of the PaLoc, but to show that the gene product is involved in regulation, we have decided to rename this gene tcdR.

C. difficile toxins

Various names have been used for C. difficile toxins in recent years (Table 1), but ‘toxin A’ and ‘toxin B’ are the most prevalent. After the first establishment of the tcd–tcs–tcn nomenclature, the toxins were also called ‘TcdA’ or ‘TcdB'. At the round table it was agreed that both prefixes, ‘Tcd’ and ‘toxin', could be used for the toxins (Table 2).

Designation of strain-specific (variant) toxins and corresponding genes

Many C. difficile strains are known to have toxin genes with marked sequence changes in comparison to the toxin genes from the reference strain VPI 10463, resulting in changed properties of the resultant toxins. If applicable, the strain identification should therefore be added to the toxin or to the toxin gene. However, the number after the locus (e.g. ‘tcdB-1470') is used as a designation of mutation site in standard genetic nomenclature (Demerec et al., 1966). To distinguish between the same genes from different strains the use of subscripts was recommended. Therefore, the designation ‘tcdB1470 for the gene and ‘TcdB1470’ or ‘toxin B1470 for the protein should be used, when appropriate.

Other LCTs and corresponding genes

As already mentioned, the tcd–tcs–tcn nomenclature applies to the entire group of related LCTs. Only one change was suggested by the nomenclature discussion group. According to standard rules (Demerec et al., 1966), genes should have a three-letter designation followed by a Latin capital letter (not Greek). Therefore the C. novyi alpha toxin gene was renamed tcnA (Table 2).

Binary toxin

The third known toxin produced by C. difficile, the binary toxin CDT (Perelle et al., 1997), is not related to TcdA and TcdB and the nomenclature of this toxin and the corresponding genes was not discussed. The names currently used are ‘C. difficile binary toxin’ or ‘binary toxin CDT'. The term ‘CDT’ should not be used alone as it could be confused with cytolethal distending toxins produced by several other bacteria. The genes are already designated cdtB for the binding component and cdtA for the enzymic component, and we suggest that these gene names be retained.

Strains – description of toxin production

In early studies, C. difficile strains always produced either both toxins, TcdA and TcdB, or neither of them, making the discrimination between toxigenic and nontoxigenic strains easy. During the last decade, however, this definition has become unclear for two reasons. First, strains producing only one of the toxins have been described and have been repeatedly isolated all over the world (AB+ or ‘toxin A-negative, toxin B-positive strains'). Secondly, a third toxin (binary toxin CDT) has been found in some C. difficile strains and, although the majority of binary toxin positive strains still produce TcdA and TcdB (A+B+CDT+ strains), up to 2 % are estimated to produce only binary toxin CDT but not TcdA and TcdB (ABCDT+ strains). Therefore, the nomenclature discussion group agreed on the following definition of toxigenic and nontoxigenic strains.

Toxigenic strains must produce at least one of the three known toxins. At the present time, five toxin production patterns can be differentiated (Table 3). Toxin production types should be described as A+B+, AB, AB+, etc. The term ‘toxin-positive’ should be avoided unless it is specifically defined in the text to which of the three toxins it refers. If the production of binary toxin CDT was also tested, toxin production type would be A+B+CDT+, etc. If the toxin designation is based on gene identification only we suggest using the toxin designation in parentheses, with an additional text commentary to indicate the basis of presumptive toxin production, e.g. A+B+(CDT+) based on PCR amplification of cdtB. The term ‘nontoxigenic strain’ should be reserved for strains known not to produce any of these three toxins.


View this table:
[in this window]
[in a new window]
 
Table 3. C. difficile toxin production types + and – refer to the toxin production and not to the presence of toxin genes tcdA, tcdB, cdtA and cdtB.
 


    REFERENCES
 TOP
 INTRODUCTION
 REVISED NOMENCLATURE
 REFERENCES
 

  • Braun, V., Hundsberger, T., Leukel, P., Sauerborn, M. & von Eichel-Streiber, C. (1996). Definition of the single integration site of the pathogenicity locus in Clostridium difficile. Gene 181, 29–38.[CrossRef][Medline]

  • Demerec, M., Adelberg, E. A., Clark, A. J. & Hartman, P. E. (1966). A proposal for a uniform nomenclature in bacterial genetics. Genetics 54, 61–76.[Free Full Text]

  • Dove, C. H., Wang, S.-Z., Price, S. B., Phelps, C. J., Lyerly, D. M., Wilkins, T. D. & Johnson, J. L. (1990). Molecular characterization of the Clostridium difficile toxin A gene. Infect Immun 58, 480–488.[Abstract/Free Full Text]

  • Dupuy, B. & Sonenshein, L. (1998). Regulated transcription of Clostridium difficile toxin genes. Mol Microbiol 27, 107–120.[CrossRef][Medline]

  • Fiorentini, C., Fabbri, A., Falzano, L., Fattorossi, A., Matarrese, P., Rivabene, R. & Donelli, G. (1998). Clostridium difficile toxin B induces apoptosis in intestinal cultured cells. Infect Immun 66, 2660–2665.[Abstract/Free Full Text]

  • Green, G. A., Schué, V. & Monteil, H. (1995). Cloning and characterization of the cytotoxin L-encoding gene of Clostridium sordellii: homology with Clostridium difficile cytotoxin B. Gene 161, 57–61.[CrossRef][Medline]

  • Hacker, J., Hochhut, B., Middendorf, B., Schneider, G., Buchrieser, C., Gottschalk, G. & Dobrindt, U. (2004). Pathogenomics of mobile genetic elements of toxigenic bacteria. Int J Med Microbiol 293, 453–461.[CrossRef][Medline]

  • Hammond, G. A. & Johnson, J. L. (1995). The toxinogenic element of Clostridium difficile strain VPI 10463. Microb Pathog 19, 203–213.[CrossRef][Medline]

  • Hammond, G. A., Lyerly, D. M. & Johnson, J. L. (1997). Transcriptional analysis of the toxigenic element of Clostridium difficile. Microb Pathog 22, 143–154.[CrossRef][Medline]

  • Hofmann, F., Herrmann, A., Habermann, E. & von Eichel Streiber, C. (1995). Sequencing and analysis of the gene encoding the {alpha}-toxin of Clostridium novyi proves its homology to toxins A and B of Clostridium difficile. Mol Gen Genet 247, 670–679.[CrossRef][Medline]

  • Hundsberger, T., Braun, V., Weidman, M., Leukel, P., Sauerborn, M. & von Eichel-Streiber, C. (1997). Transcription analysis of the genes tcdA-E of the pathogenicity locus of Clostridium difficile. Eur J Biochem 244, 735–742.[Medline]

  • Johnson, J. L., Phelps, C., Barroso, L., Roberts, M. D., Lyerly, D. M. & Wilkins, T. D. (1990). Cloning and expression of the toxin B gene of Clostridium difficile. Curr Microbiol 20, 397–401.

  • Karlsson, S., Dupuy, B., Mukherjee, K., Norin, E., Burman, L. G. & Akerlund, T. (2003). Expression of Clostridium difficile toxins A and B and their sigma factor TcdD is controlled by temperature. Infect Immun 71, 1784–1793.[Abstract/Free Full Text]

  • Mani, N. & Dupuy, B. (2001). Regulation of toxin synthesis in Clostridium difficile by an alternative RNA polymerase sigma factor. Proc Natl Acad Sci U S A 98, 5844–5849.[Abstract/Free Full Text]

  • Moncrief, J. S., Barroso, L. A. & Wilkins, T. D. (1997). Positive regulation of Clostridium difficile toxins. Infect Immun 65, 1105–1108.[Abstract]

  • Niemann, H. (1992). Clostridial neurotoxins – proposal of a common nomenclature. Toxicon 30, 223–225.[Medline]

  • Perelle, S., Gibert, M., Bourlioux, P., Corthier, G. & Popoff, M. R. (1997). Production of a complete binary toxin (actin-specific ADP-ribosyltransferase) by Clostridium difficile CD196. Infect Immun 65, 1402–1407.[Abstract]

  • Spigaglia, P. & Mastrantonio, P. (2002). Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates. J Clin Microbiol 40, 3470–3475.[Abstract/Free Full Text]

  • von Eichel-Streiber, C. & Sauerborn, M. (1990). Clostridium difficile toxin A carries a C-terminal repetitive structure homologous to the carbohydrate binding region of streptococcal glycosyltransferases. Gene 96, 107–113.[CrossRef][Medline]

  • von Eichel-Streiber, C., Laufenberg-Feldmann, R., Sartringen, S., Schulze, J. & Sauerborn, M. (1990). Cloning of Clostridium difficile toxin B gene and demonstration of high N-terminal homology between toxin A and B. Med Microbiol Immunol 179, 271–279.[Medline]

  • von Eichel-Streiber, C., Laufenberg-Feldmann, R., Sartingen, S., Shulze, J. & Sauerborn, M. (1992). Comparative sequence analysis of the Clostridium difficile toxins A and B. Mol Gen Genet 233, 260–268.[CrossRef][Medline]

  • von Eichel-Streiber, C., Boquet, P., Sauerborn, M. & Thelestam, M. (1996). Large clostridial cytotoxins – a family of glycosyltransferases modifying small GTP-binding proteins. Trends Microbiol 4, 375–382.[CrossRef][Medline]




    This article has been cited by other articles:


    Home page
    J. Clin. Microbiol.Home page
    P. J. M. Bouvet and M. R. Popoff
    Genetic Relatedness of Clostridium difficile Isolates from Various Origins Determined by Triple-Locus Sequence Analysis Based on Toxin Regulatory Genes tcdC, tcdR, and cdtR
    J. Clin. Microbiol., November 1, 2008; 46(11): 3703 - 3713.
    [Abstract] [Full Text] [PDF]


    Home page
    Antimicrob. Agents Chemother.Home page
    E. Kokkotou, A. C. Moss, A. Michos, D. Espinoza, J. W. Cloud, N. Mustafa, M. O'Brien, C. Pothoulakis, and C. P. Kelly
    Comparative Efficacies of Rifaximin and Vancomycin for Treatment of Clostridium difficile-Associated Diarrhea and Prevention of Disease Recurrence in Hamsters
    Antimicrob. Agents Chemother., March 1, 2008; 52(3): 1121 - 1126.
    [Abstract] [Full Text] [PDF]


    Home page
    MicrobiologyHome page
    K. Amimoto, T. Noro, E. Oishi, and M. Shimizu
    A novel toxin homologous to large clostridial cytotoxins found in culture supernatant of Clostridium perfringens type C
    Microbiology, April 1, 2007; 153(4): 1198 - 1206.
    [Abstract] [Full Text] [PDF]


    Home page
    MicrobiologyHome page
    S. Goh, P. F. Ong, K. P. Song, T. V. Riley, and B. J. Chang
    The complete genome sequence of Clostridium difficile phage {phi}C2 and comparisons to {phi}CD119 and inducible prophages of CD630
    Microbiology, March 1, 2007; 153(3): 676 - 685.
    [Abstract] [Full Text] [PDF]


    Home page
    J. Bacteriol.Home page
    N. Mani, B. Dupuy, and A. L. Sonenshein
    Isolation of RNA Polymerase from Clostridium difficile and Characterization of Glutamate Dehydrogenase and rRNA Gene Promoters In Vitro and In Vivo
    J. Bacteriol., January 1, 2006; 188(1): 96 - 102.
    [Abstract] [Full Text] [PDF]


    Home page
    CVIHome page
    Z. Zhao, F. Kong, and G. L. Gilbert
    Reverse Line Blot Assay for Direct Identification of Seven Streptococcus agalactiae Major Surface Protein Antigen Genes
    Clin. Vaccine Immunol., January 1, 2006; 13(1): 145 - 149.
    [Abstract] [Full Text] [PDF]


    Home page
    Proc. Natl. Acad. Sci. USAHome page
    J. G. S. Ho, A. Greco, M. Rupnik, and K. K.-S. Ng
    Crystal structure of receptor-binding C-terminal repeats from Clostridium difficile toxin A
    PNAS, December 20, 2005; 102(51): 18373 - 18378.
    [Abstract] [Full Text] [PDF]


    Home page
    J Med MicrobiolHome page
    I. R Poxton
    Clostridium difficile
    J. Med. Microbiol., February 1, 2005; 54(2): 97 - 100.
    [Full Text] [PDF]


    This Article
    Right arrow Abstract Freely available
    Right arrow Full Text (PDF)
    Right arrow Alert me when this article is cited
    Right arrow Alert me if a correction is posted
    Right arrow Citation Map
    Services
    Right arrow Email this article to a friend
    Right arrow Similar articles in this journal
    Right arrow Similar articles in PubMed
    Right arrow Alert me to new issues of the journal
    Right arrow Download to citation manager
    Right arrow reprints & permissions
    Citing Articles
    Right arrow Citing Articles via HighWire
    Right arrow Citing Articles via CrossRef
    Right arrow Citing Articles via Google Scholar
    Google Scholar
    Right arrow Articles by Rupnik, M.
    Right arrow Articles by von Eichel-Streiber, C.
    Right arrow Search for Related Content
    PubMed
    Right arrow PubMed Citation
    Right arrow Articles by Rupnik, M.
    Right arrow Articles by von Eichel-Streiber, C.
    Agricola
    Right arrow Articles by Rupnik, M.
    Right arrow Articles by von Eichel-Streiber, C.


    HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
    INT J SYST EVOL MICROBIOL J MED MICROBIOL MICROBIOLOGY J GEN VIROL ALL SGM JOURNALS